Suppression of RRM2 inhibits cell proliferation, causes cell cycle arrest and promotes the apoptosis of human neuroblastoma cells and in human neuroblastoma RRM2 is suppressed following chemotherapy DOI Open Access
Junfeng Li,

Jinglin Pang,

Yongdong Liu

et al.

Oncology Reports, Journal Year: 2018, Volume and Issue: unknown

Published: May 8, 2018

Language: Английский

A sensitive assay for dNTPs based on long synthetic oligonucleotides, EvaGreen dye and inhibitor-resistant high-fidelity DNA polymerase DOI Creative Commons
Janne Purhonen, Rishi Banerjee, Allison E. McDonald

et al.

Nucleic Acids Research, Journal Year: 2020, Volume and Issue: 48(15), P. e87 - e87

Published: June 5, 2020

Deoxyribonucleoside triphosphates (dNTPs) are vital for the biosynthesis and repair of DNA. Their cellular concentration peaks during S phase cell cycle. In non-proliferating cells, dNTP concentrations low, making their reliable quantification from tissue samples heterogeneous composition challenging. Partly because this, current knowledge related to regulation disturbances in derive mostly culture experiments with little corroboration at or organismal level. Here, we fill methodological gap by presenting a simple non-radioactive microplate assay dNTPs minimum requirement 4-12 mg biopsy material. contrast published assays, this is based on long synthetic single-stranded DNA templates (50-200 nucleotides), an inhibitor-resistant high-fidelity polymerase, double-stranded-DNA-binding EvaGreen dye. The quantified reliably less than 50 fmol each four discriminated well against ribonucleotides. Additionally, thermostable RNAse HII-mediated nicking reaction products subsequent shift melting temperature allowed near-complete elimination interfering ribonucleotide signal, if present. Importantly, measurement minute mouse liver, heart skeletal muscle.

Language: Английский

Citations

550

Hallmarks of DNA replication stress DOI Creative Commons
Sneha Saxena, Lee Zou

Molecular Cell, Journal Year: 2022, Volume and Issue: 82(12), P. 2298 - 2314

Published: June 1, 2022

Language: Английский

Citations

234

Replication Catastrophe: When a Checkpoint Fails because of Exhaustion DOI Creative Commons
Luis Toledo, Kai J. Neelsen, Jiří Lukáš

et al.

Molecular Cell, Journal Year: 2017, Volume and Issue: 66(6), P. 735 - 749

Published: June 1, 2017

Language: Английский

Citations

195

Anticancer Thiosemicarbazones: Chemical Properties, Interaction with Iron Metabolism, and Resistance Development DOI
Petra Heffeter, Veronika F.S. Pape, Éva A. Enyedy

et al.

Antioxidants and Redox Signaling, Journal Year: 2018, Volume and Issue: 30(8), P. 1062 - 1082

Published: Jan. 16, 2018

During the past decades, thiosemicarbazones were clinically developed for a variety of diseases, including tuberculosis, viral infections, malaria, and cancer. With regard to malignant class α-N-heterocyclic thiosemicarbazones, here especially 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (Triapine), was intensively in multiple clinical phase I/II trials. Recent Advances: Very recently, two new derivatives, namely COTI-2 di-2-pyridylketone 4-cyclohexyl-4-methyl-3-thiosemicarbazone (DpC) have entered I evaluation. Based on strong metal-chelating/metal-interacting properties interference with cellular iron (and copper) homeostasis is assumed play an important role their biological activity.In this review, we summarize analyze data interaction (α-N-heterocyclic) iron, special aim bridging current knowledge mode action from chemistry (cell) biology. In addition, highlight difference classical iron(III) chelators such as desferrioxamine (DFO), which are used treatment overload.We want emphasize that not solely removing cells/organism. contrast, they should be considered iron-interacting drugs influencing diverse pathways complex multi-faceted action. Consequently, addition discussion physicochemical (e.g., stability, redox activity), review contains overview diversity targets drug resistance mechanisms.

Language: Английский

Citations

175

Key Proteins of Replication Stress Response and Cell Cycle Control as Cancer Therapy Targets DOI Open Access
Alvina I. Khamidullina, Yaroslav E. Abramenko, Alexandra V. Bruter

et al.

International Journal of Molecular Sciences, Journal Year: 2024, Volume and Issue: 25(2), P. 1263 - 1263

Published: Jan. 19, 2024

Replication stress (RS) is a characteristic state of cancer cells as they tend to exchange precision replication for fast proliferation and increased genomic instability. To overcome the consequences improper control, malignant frequently inactivate parts their DNA damage response (DDR) pathways (the ATM-CHK2-p53 pathway), while relying on other which help maintain fork stability (ATR-CHK1). This creates dependency remaining DDR pathways, vulnerability further destabilization synthetic lethality inhibitors with common oncogenic alterations such mutations TP53, RB1, ATM, amplifications MYC, CCNE1 others. The RS normally limited by coordination cell cycle, transcription replication. Inhibition WEE1 PKMYT1 kinases, prevent unscheduled mitosis entry, leads fragility under-replicated sites. Recent evidence also shows that inhibition Cyclin-dependent kinases (CDKs), CDK4/6, CDK2, CDK8/19 CDK12/13 can contribute through disruption repair control. Here, we review main causes in cancers well therapeutic targets—ATR, CHK1, PARP inhibitors.

Language: Английский

Citations

21

Metabolic Rewiring in the Face of Genomic Assault: Integrating DNA Damage Response and Cellular Metabolism DOI Creative Commons
Wenjian Ma, Sa Zhou

Biomolecules, Journal Year: 2025, Volume and Issue: 15(2), P. 168 - 168

Published: Jan. 23, 2025

The DNA damage response (DDR) and cellular metabolism exhibit a complex, bidirectional relationship crucial for maintaining genomic integrity. Studies across multiple organisms, from yeast to humans, have revealed how cells rewire their in damage, supporting repair processes homeostasis. We discuss immediate metabolic shifts upon detection long-term reprogramming sustained stability, highlighting key signaling pathways participating molecules. Importantly, we examine can conversely induce changes oxidative stress through specific mechanisms, including the histone H2A variant X (H2AX)/ataxia telangiectasia mutated (ATM)/NADPH oxidase 1 (Nox1) pathway repair-specific ROS signatures. review covers organelle-specific responses adaptations associated with different primary focus on human cells. explore implications of this DDR–metabolism crosstalk cancer, aging, neurodegenerative diseases, emerging therapeutic opportunities. By integrating recent findings, provides comprehensive overview intricate interplay between DDR metabolism, offering new perspectives resilience potential avenues intervention.

Language: Английский

Citations

3

Thiosemicarbazones as Potent Anticancer Agents and their Modes of Action DOI
Bhushan Shakya, Paras Nath Yadav

Mini-Reviews in Medicinal Chemistry, Journal Year: 2019, Volume and Issue: 20(8), P. 638 - 661

Published: Oct. 29, 2019

: Thiosemicarbazones (TSCs) are a class of Schiff bases usually obtained by the condensation thiosemicarbazide with suitable aldehyde or ketone. TSCs have been focus chemists and biologists due to their wide range pharmacological effects. One promising areas in which these excellent metal chelators being developed is use against cancer. clinical antitumor spectrum efficacy various tumor types such as leukemia, pancreatic cancer, breast non-small cell lung cervical prostate cancer bladder To obtain better activity, different series modifying heteroaromatic system molecules. These compounds possessed significant antineoplastic activity when carbonyl attachment side chain was located at position α ring nitrogen atom, whereas β γ heterocyclic N atom resulted inactive agents. In addition, replacement C also biologically compound suggesting that conjugated N,N,S-tridentate donor set essential for biological activities thiosemicarbazones. Several possible mechanisms implemented anticancer

Language: Английский

Citations

98

Role of Rad51 and DNA repair in cancer: A molecular perspective DOI
Erik Laurini, Domenico Marson,

Alice Fermeglia

et al.

Pharmacology & Therapeutics, Journal Year: 2020, Volume and Issue: 208, P. 107492 - 107492

Published: Jan. 27, 2020

Language: Английский

Citations

90

5-Fluorouracil Enhances the Antitumor Activity of the Glutaminase Inhibitor CB-839 against PIK3CA-Mutant Colorectal Cancers DOI
Yiqing Zhao, Xiujing Feng, Yicheng Chen

et al.

Cancer Research, Journal Year: 2020, Volume and Issue: 80(21), P. 4815 - 4827

Published: Sept. 9, 2020

Abstract PIK3CA encodes the p110α catalytic subunit of PI3K and is frequently mutated in human cancers, including ∼30% colorectal cancer. Oncogenic mutations render cancers more dependent on glutamine. Here we report that glutaminase inhibitor CB-839 preferentially inhibits xenograft growth PIK3CA-mutant, but not wild-type (WT), cancers. Moreover, combination 5-fluorouracil (5-FU) induces PIK3CA-mutant tumor regression models. treatment increased reactive oxygen species caused nuclear translocation Nrf2, which turn upregulated mRNA expression uridine phosphorylase 1 (UPP1). UPP1 facilitated conversion 5-FU to its active compound, thereby enhancing inhibition thymidylate synthase. Consistently, knockout abrogated inhibitory effect combined administration. A phase I clinical trial showed capecitabine, a prodrug 5-FU, was well tolerated at biologically-active doses. Although designed test efficacy, an exploratory analysis data trend patients with cancer might derive greater benefit from this strategy as compared WT These results effectively demonstrate targeting glutamine metabolism may be effective approach for treating warrants further evaluation. Significance: Preclinical suggest capecitabine could serve

Language: Английский

Citations

78

Unprocessed genomic uracil as a source of DNA replication stress in cancer cells DOI
Sneha Saxena, Christopher S. Nabel, Turner W. Seay

et al.

Molecular Cell, Journal Year: 2024, Volume and Issue: 84(11), P. 2036 - 2052.e7

Published: April 29, 2024

Language: Английский

Citations

17